Sunil Patel

6.9k total citations · 4 hit papers
44 papers, 4.2k citations indexed

About

Sunil Patel is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Sunil Patel has authored 44 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Ophthalmology, 23 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Molecular Biology. Recurrent topics in Sunil Patel's work include Retinal Diseases and Treatments (25 papers), Retinal Imaging and Analysis (15 papers) and Retinal and Optic Conditions (8 papers). Sunil Patel is often cited by papers focused on Retinal Diseases and Treatments (25 papers), Retinal Imaging and Analysis (15 papers) and Retinal and Optic Conditions (8 papers). Sunil Patel collaborates with scholars based in United States, Switzerland and United Kingdom. Sunil Patel's co-authors include David S. Boyer, Jason S. Ehrlich, Quan Dong Nguyen, J. Jill Hopkins, Dennis M. Marcus, Roman G. Rubio, Leonard Feiner, Amy Chen Rundle, Peter E. Lipsky and David M. Brown and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Sunil Patel

43 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ranibizumab for Diabetic Macular Edema

2012 1.2k citations Quan Dong Nguyen, David M. Brown et al. Ophthalmology profile →
Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

2013 650 citations Quan Dong Nguyen, Dennis M. Marcus et al. Ophthalmology profile →
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration

2020 307 citations Glenn J. Jaffe, Keith Westby et al. Ophthalmology profile →
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

2023 82 citations Sunil Patel, David R. Lally et al. Eye profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sunil Patel United States	22	3.2k	2.6k	950	649	195	44	4.2k
Tammy Huang United States	10	423 0.1×	523 0.2×	1.2k 1.3×	414 0.6×	512 2.6×	16	2.7k
Vanessa Chisholm United States	12	208 0.1×	422 0.2×	1.6k 1.7×	175 0.3×	607 3.1×	14	2.4k
Hiroshi Tanaka Japan	21	245 0.1×	606 0.2×	878 0.9×	72 0.1×	494 2.5×	66	2.1k
An Song United States	20	88 0.0×	684 0.3×	1.1k 1.1×	610 0.9×	381 2.0×	39	1.8k
Raymond Tubbs United States	28	133 0.0×	283 0.1×	815 0.9×	706 1.1×	936 4.8×	72	2.5k
Maria Antonia Frassanito Italy	30	180 0.1×	106 0.0×	1.3k 1.4×	723 1.1×	738 3.8×	68	2.5k
Ami B. Patel United States	22	222 0.1×	76 0.0×	586 0.6×	351 0.5×	805 4.1×	62	1.8k
Samia Mourah France	33	74 0.0×	183 0.1×	1.5k 1.6×	582 0.9×	1.3k 6.5×	162	3.1k
Friedrich Prall Germany	28	80 0.0×	241 0.1×	479 0.5×	274 0.4×	1.5k 7.5×	80	2.4k
R.C. Rees United Kingdom	17	97 0.0×	104 0.0×	402 0.4×	581 0.9×	382 2.0×	29	1.4k

Countries citing papers authored by Sunil Patel

Since Specialization

Citations

This map shows the geographic impact of Sunil Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Patel more than expected).

Fields of papers citing papers by Sunil Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Patel. The network helps show where Sunil Patel may publish in the future.

Co-authorship network of co-authors of Sunil Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Sunil Patel. A scholar is included among the top collaborators of Sunil Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunil Patel. Sunil Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Sunil, Philip Storey, Mark Barakat, et al.. (2024). Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration. Ophthalmology Science. 4(5). 100527–100527. 6 indexed citations

Callanan, David, Rahul N. Khurana, Raj K. Maturi, et al.. (2023). Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results. Clinical ophthalmology. Volume 17. 1367–1384. 6 indexed citations

Patel, Sunil, David R. Lally, Jason Hsu, et al.. (2023). Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye. 37(17). 3551–3557. 82 indexed citations breakdown →

Khanani, Arshad M., Sunil Patel, Víctor H. González, et al.. (2021). Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema. SHILAP Revista de lepidopterología. 1(3). 100040–100040. 13 indexed citations

Patel, Sunil, et al.. (2020). Updated Results of Phase 1b Study of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate with Extended Durability, in wAMD, DME, and RVO. Investigative Ophthalmology & Visual Science. 61(7). 4286–4286. 14 indexed citations

Jaffe, Glenn J., Keith Westby, Karl G. Csaky, et al.. (2020). C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration. Ophthalmology. 128(4). 576–586. 307 indexed citations breakdown →

Nguyen, Quan Dong, Yasir J. Sepah, Brian B. Berger, et al.. (2019). Primary outcomes of the VIDI study: phase 2, double-masked, randomized, active-controlled study of ASP8232 for diabetic macular edema. International Journal of Retina and Vitreous. 5(1). 28–28. 14 indexed citations

Sahni, Jayashree, Sunil Patel, Pravin U. Dugel, et al.. (2019). Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema. Ophthalmology. 126(8). 1155–1170. 179 indexed citations

Patel, Sunil, Jayashree Sahni, Shamil Sadikhov, et al.. (2018). Anti-VEGF/anti-angiopoietin-2 bispecific antibody RG7716 in diabetic macular edema: complete 36-week results from the phase 2, multicenter, randomized, active treatment-controlled BOULEVARD clinical trial. Investigative Ophthalmology & Visual Science. 59(9). 1959–1959. 1 indexed citations

10.

Callanan, David, Derek Kunimoto, Raj K. Maturi, et al.. (2018). Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 34(10). 700–709. 55 indexed citations

11.

Callanan, David, Anat Loewenstein, Sunil Patel, et al.. (2016). A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema. Graefe s Archive for Clinical and Experimental Ophthalmology. 255(3). 463–473. 75 indexed citations

12.

Nguyen, Quan Dong, David M. Brown, Dennis M. Marcus, et al.. (2012). Ranibizumab for Diabetic Macular Edema. Ophthalmology. 119(4). 789–801. 1222 indexed citations breakdown →

13.

Isaakidis, Petros, et al.. (2012). Tracing patients on antiretroviral treatment lost‐to‐follow‐up in an urban slum in India. Journal of Advanced Nursing. 68(11). 2399–2409. 6 indexed citations

14.

Boyer, David S., David Faber, Sunil Gupta, et al.. (2011). DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF DIABETIC MACULAR EDEMA IN VITRECTOMIZED PATIENTS. Retina. 31(5). 915–923. 281 indexed citations

15.

Coffelt, Seth B., Andrea O. Tal, Alexander Scholz, et al.. (2010). Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions. Cancer Research. 70(13). 5270–5280. 268 indexed citations

16.

Capone, Antonio, Víctor H. González, Jeffrey S. Heier, et al.. (2008). A Phase I Open-Label Study of Single and Repeated Doses of Intravitreal JSM6427, a Small Molecule Integrin 5β1 Antagonist, in Neovascular Age-Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 49(13). 1259–1259. 3 indexed citations

17.

Wang, Yingxu, Sunil Patel, & Ron Johnston. (2001). OOIS 2001 : 7th International Conference on Object-Oriented Information Systems, 27-29 August 2001, Calgary, Canada : proceedings. Springer eBooks. 5 indexed citations

18.

Patel, Sunil, Dwain L. Thiele, & Peter E. Lipsky. (1993). Stimulus-Dependent Modulation of Human B Cell Function by T Cell Clones. Cellular Immunology. 146(2). 362–381. 2 indexed citations

19.

Davis, Laurie S., Sunil Patel, John Atkinson, & Peter E. Lipsky. (1988). Decay-accelerating factor functions as a signal transducing molecule for human T cells.. The Journal of Immunology. 141(7). 2246–2252. 137 indexed citations

20.

Thiele, Dwain L., Sunil Patel, & Peter E. Lipsky. (1988). Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.. The Journal of Immunology. 140(9). 3253–3260. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact